🇺🇸 FDA
Pipeline program

Tasocitinib 10 mg oral tablet

A3921077

Phase 1 small_molecule completed

Quick answer

Tasocitinib 10 mg oral tablet for Healthy is a Phase 1 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials